U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776626) titled 'Phase I Exploratory Study of YOLT-203 in Patients With Primary Hyperoxaluria Type 1 (PH1)' ... Read More
U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776977) titled 'Bedtime Device Restriction and Desmopressin in PMNE.' on Aug. 18. Brief Summary: This rand... Read More
U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777263) titled 'ADT De-escalation in Selected High-Risk Prostate Cancer Patients (ADaPPt Trial) a GROUQ Led... Read More
U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776600) titled 'VETERANS AFFAIRS AUGUSTA' on Aug. 07. Brief Summary: Chronic pain is a prevalent and debil... Read More
U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777406) titled 'Real-life Study on the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Patient... Read More
U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07775534) titled 'Tear Fluid for the Detection of Tumor-associated Extracellular Vesicles in Glioblastoma Pat... Read More
U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07775469) titled 'Comparison Study for Hemodynamic Parameters Generated by Vitalstream Relative to Appropriat... Read More
U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07775365) titled 'AI-Based Prediction of Root Coverage Outcome From Intraoral Photographs' on Aug. 16. Brief... Read More
U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776522) titled 'Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration' on Au... Read More
U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07775924) titled 'A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants... Read More